Efficacy analysis demonstrates Covaxin to be 77.8 per cent effective against symptomatic Covid-19, through evaluation of 130 confirmed cases, with 24 observed in the vaccine...

Hyderabad, June 15 (PTI): The supply price of Bharat Biotech’s Covid-19 vaccine Covaxin to the Central government at INR 150 per dose is not sustainable...

New Delhi, Mar. 4 (PTI): The Delhi High Court Thursday directed Serum Institute of India and Bharat Biotech to disclose their capacities to manufacture Covaxin,...

Dimapur, March 2 (EMN): Nagaland Governor RN Ravi on Tuesday took his first dose of Covaxin at the All India Institute of Medical Sciences (AIIMS),...

Hyderabad, Jan. 19 (IANS): Bharat Biotech, makers of India’s first indigenous vaccine for Covid-19, has advised people not to take ‘Covaxin’ if they have allergies,...

New Delhi, Jan. 13 (IANS): As the government gears up for the Covid vaccination drive targeting health care and frontline workers, the Congress has cautioned...

Bhubaneswar, Nov. 20 (IANS): The third phase human trial of Covid-19 vaccine candidate ‘Covaxin’ began at the Institute of Medical Sciences and SUM Hospital here,...

Guwahati, Aug 18 (IANS): The Gauhati Medical College and Hospital (GMCH) has been selected for the second phase clinical testing of India’s indigenously developed coronavirus...

New Delhi, July 5 (IANS): As India races to bring a vaccine for Covid-19 by mid August, the government on Sunday said that it is...